Price$1.34+0.22 (+19.11%)
01:30 PM04:30 PM
News · 26 weeks62-11%
2026-02-082026-08-02
Mix3790d
- Insider22(59%)
- SEC Filings9(24%)
- Other3(8%)
- Earnings2(5%)
- Leadership1(3%)
Latest news
25 items- SECSEC Form S-8 filed by Myomo Inc.S-8 - MYOMO, INC. (0001369290) (Filer)
- SECSEC Form 10-Q filed by Myomo Inc.10-Q - MYOMO, INC. (0001369290) (Filer)
- SECMyomo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MYOMO, INC. (0001369290) (Filer)
- PRMyomo Reports Second Quarter 2026 Financial and Operating ResultsRevenue of $11.7 million, increased 21% year over year Four success pillars driving higher revenue growth and operating leverage Raising full year revenue guidance to $45-47 million Conference call begins at 4:30pm Eastern time today Myomo, Inc. (NYSE:MYO)("Myomo" or the "Company"), a wearable medical robotics platform company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2026. "I am pleased to report that the evolution of our go-to-market approach is driving positive results. Revenue of $11.7 million exceeded our expectations, with 53% of second
- PRMyomo to Report Second Quarter 2026 Financial Results on August 5Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter ended June 30, 2026 on Wednesday, August 5, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions.Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call star
- INSIDERChief Financial Officer Henry David A was granted 7,840 shares and covered exercise/tax liability with 5,166 shares, increasing direct ownership by 0.63% to 426,829 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Executive Officer Gudonis Paul R was granted 10,454 shares, increasing direct ownership by 0.82% to 1,287,770 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- SECSEC Form 144 filed by Myomo Inc.144 - MYOMO, INC. (0001369290) (Subject)
- SECAmendment: Myomo Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K/A - MYOMO, INC. (0001369290) (Filer)
- INSIDERDirector Manko Joseph M. Jr. was granted 78,704 shares (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Crowley Thomas Aloysius Jr. was granted 78,704 shares, increasing direct ownership by 104% to 154,452 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Kirk Thomas F was granted 78,704 shares, increasing direct ownership by 11% to 772,569 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Getz Heather C was granted 78,704 shares, increasing direct ownership by 60% to 210,458 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Febbo William J was granted 78,704 shares, increasing direct ownership by 175% to 123,704 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Morris Milton Mayo was granted 78,704 shares, increasing direct ownership by 54% to 223,391 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- SECMyomo Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - MYOMO, INC. (0001369290) (Filer)
- PRMyomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment ConferenceMyomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, taking place June 23–24, 2026. President and Chief Executive Officer Paul Gudonis and Chief Financial Officer David Henry will deliver a presentation at 1:00 p.m. ET on June 23 and participate in one-on-one meetings with pre-qualified investors on June 24. The live webcast of the presentation can be found here, and a replay will be accessible following the event. iAccess Alpha hosts virtu
- INSIDERChief Medical Officer Kovelman Harry covered exercise/tax liability with 10,442 shares, decreasing direct ownership by 10% to 90,541 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Commercial Officer Mitchell Micah covered exercise/tax liability with 9,061 shares, decreasing direct ownership by 9% to 93,888 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Financial Officer Henry David A covered exercise/tax liability with 10,969 shares, decreasing direct ownership by 3% to 424,155 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Commercial Officer Mitchell Micah covered exercise/tax liability with 6,529 shares, decreasing direct ownership by 6% to 102,949 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Medical Officer Kovelman Harry covered exercise/tax liability with 7,635 shares, decreasing direct ownership by 7% to 100,983 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERChief Financial Officer Henry David A covered exercise/tax liability with 10,050 shares, decreasing direct ownership by 2% to 435,124 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERDirector Kirk Thomas F bought $50,803 worth of shares (40,002 units at $1.27), increasing direct ownership by 6% to 693,865 units (SEC Form 4)4 - MYOMO, INC. (0001369290) (Issuer)
- INSIDERAmendment: Chief Commercial Officer Mitchell Micah sold $77,689 worth of shares (90,231 units at $0.86), decreasing direct ownership by 45% to 109,478 units (SEC Form 4)4/A - MYOMO, INC. (0001369290) (Issuer)
MYO FAQ
7 questionsWhat does Myomo Inc. do?
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The...Where does MYO stock trade?
Myomo Inc. (MYO) is listed on AMEX.What sector and industry is MYO in?
Myomo Inc. operates in the Health Care sector, Industrial Specialties industry.When did Myomo Inc. go public?
Myomo Inc. (MYO) completed its IPO in 2017.What are analysts saying about MYO?
Myomo Inc. has had 3 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $700.00 price target on 2024-07-31. Recent price targets range from $650.00 to $700.00.What companies are similar to MYO?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare MYO side-by-side with any of them on Quantisnow.How can I track MYO on Quantisnow?
Quantisnow aggregates Myomo Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MYO to receive live email and push alerts on every new disclosure.